A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Rosuvastatin Impurity 55 - Request Quote

Picture of Rosuvastatin Impurity 55

Rosuvastatin Impurity 55

SZ CAT No:SZ-R020154
CAS No
NA
Mol.F.
C14H13FN2O3
Mol.Wt.
276.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Rosuvastatin Impurity 55 is chemically 4-(4-Fluorophenyl)-2-hydroxy-6-isopropylpyrimidine-5-carboxylic acid. Rosuvastatin Impurity 55 is supplied with detailed characterization data compliant with regulatory guideline. Rosuvastatin Impurity 55 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rosuvastatin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Rosuvastatin Impurity 55

Purchase Rosuvastatin Impurity 55

Rosuvastatin Impurity 55 suppliers

Rosuvastatin Impurity 55 manufacturers

Rosuvastatin Impurity 55 price

Order Rosuvastatin Impurity 55

Enquire Rosuvastatin Impurity 55

Rosuvastatin Impurity 55 cost

Rosuvastatin Impurity 55 Supplier

Rosuvastatin Impurity 55 Distributor

Rosuvastatin Impurity 55 for Method Validation

Rosuvastatin Reference Standard

Rosuvastatin Impurity 55 for ANDA Filing

Rosuvastatin Impurity 55 for Forced Degradation Studies

Rosuvastatin Impurity 55 Identification Standards

Rosuvastatin Impurity 55 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,